Management of Recurrent Intrahepatic Cholestasis of Pregnancy: A Case  Report

Mohadese  Dashtkoohi; Mohammad  Sadeq Najafi; Zohreh  Heidary; Afsaneh  Alimadad-Tafreshi; Seyedeh Mojgan  Ghalandarpoor-Attar; Sedigheh  Hantoushzadeh

doi:10.18502/jri.v26i3.20186

Mohadese Dashtkoohi Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Imam Khomeini Hospital Complex, Tehran Uni-versity of Medical Sciences, Tehran, Iran
Mohammad Sadeq Najafi Tehran University of Medical Sciences, Tehran, Iran
Zohreh Heidary Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Imam Khomeini Hospital Complex, Tehran Uni-versity of Medical Sciences, Tehran, Iran
Afsaneh Alimadad-Tafreshi Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Imam Khomeini Hospital Complex, Tehran Uni-versity of Medical Sciences, Tehran, Iran
Seyedeh Mojgan Ghalandarpoor-Attar Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Imam Khomeini Hospital Complex, Tehran Uni-versity of Medical Sciences, Tehran, Iran
Sedigheh Hantoushzadeh Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Imam Khomeini Hospital Complex, Tehran Uni-versity of Medical Sciences, Tehran, Iran

DOI: https://doi.org/10.18502/jri.v26i3.20186

Keywords: Bile acids, Fetal distress, Intrahepatic cholestasis of pregnancy, Intrauterine fetal death, Mul-tidisciplinary management, Pruritus

Abstract

Background: Intrahepatic cholestasis of pregnancy (ICP) is the most prevalent hepatic disorder exclusive to pregnancy, associated with significant maternal morbidity and increased risk of adverse perinatal outcomes. Recurrence in subsequent pregnancies and comorbidities such as gestational diabetes and hypertensive disorders further complicate clinical management. This case presentation, an attempted to describe the diagnostic and therapeutic challenges in managing recurrent ICP, especially in the context of overlapping maternal comorbidities and limited diagnostic resources.

Case Presentation: A case of a 32-year-old Iranian woman, gravida 3 para 2, with a history of one intrauterine fetal death and one neonatal death, was ultimately diagnosed with recurrent ICP. In her third pregnancy, elevated bile acid levels were confirmed by routine monitoring from 20 weeks’ gestation, peaking at 333 µmol/L by 32 weeks. Despite intensive medical therapy including ursodeoxycholic acid, hydroxychloroquine, corticosteroids, and low-molecular-weight heparin, her pruritus worsened and bile acid levels escalated, prompting preterm cesarean delivery. The neonate experienced complications, including respiratory distress, suspected Hirschsprung’s disease, sepsis, and hyperbilirubinemia. Management included continuous positive airway pressure (CPAP), broad-spectrum antibiotics, surgery, phototherapy, and parenteral nutrition. Multidisciplinary intervention enabled neonatal recovery, and maternal symptoms resolved postpartum.

Conclusion: This case underscores the complexities of managing recurrent ICP, particularly in resource-limited settings. It highlights the critical need for early diagnosis, vigilant monitoring, and a multidisciplinary approach to mitigate the risk of stillbirth and improve perinatal outcomes. Additionally, it suggests that recurrent ICP may present earlier or with greater intensity in subsequent pregnancies, necessitating more comprehensive surveillance and tailored management strategies for affected mothers.